Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06687759
PHASE1
A Study of Calderasib (MK-1084) Human Absorption, Distribution, Metabolism, and Excretion in Healthy Adult Participants (MK-1084-006)
Sponsor: Merck Sharp & Dohme LLC
View on ClinicalTrials.gov
Summary
The purpose of this study is to learn what happens to calderasib in a healthy person's body over time and how it is cleared from the body.
Official title: A Phase 1 Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of [14C]MK-1084 in Healthy Adult Participants
Key Details
Gender
MALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2024-06-26
Completion Date
2024-08-07
Last Updated
2026-04-13
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
[14C]Calderasib
Oral administration
Locations (1)
Fortea CRU Madison (Site 0001)
Madison, Wisconsin, United States